At a glance
- Originator Ligand Pharmaceuticals
- Class
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome; Pregnancy
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Menopausal syndrome in USA (Unknown route)
- 07 Feb 2001 Discontinued-Preclinical for Pregnancy (Prevention) in USA (Unknown route)
- 08 Apr 1999 New profile